Thomas Sbarrato

Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial

Carlotta Antoniotti, Daniele Rossini, Filippo Pietrantonio et al. · The Lancet Oncology · 2022 · 246 citations · Full text

Oncology, Clinical Trials, Colorectal Cancer +9

The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape

A. Modelska, Ernest Turro, Robert B. Russell et al. · Cell Death and Disease · 2015 · 167 citations · Full text

RTN3 Is a Novel Cold-Induced Protein and Mediates Neuroprotective Effects of RBM3

Amandine Bastide, Diego Peretti, John R. P. Knight et al. · Current Biology · 2017 · 83 citations · Full text

Suboptimal T-cell receptor signaling compromises protein translation, ribosome biogenesis, and proliferation of mouse CD8 T cells

Thomas C. J. Tan, John R. P. Knight, Thomas Sbarrato et al. · Proceedings of the National Academy of Sciences · 2017 · 79 citations · Full text

Inhibition of Sec61-dependent translocation by mycolactone uncouples the integrated stress response from ER stress, driving cytotoxicity via translational activation of ATF4

Joy Ogbechi, Belinda S. Hall, Thomas Sbarrato et al. · Cell Death and Disease · 2018 · 79 citations · Full text